Antonis Valachis

Insights on postneoadjuvant treatment among patients with triple-negative breast cancer and residual disease after neoadjuvant therapy: can expert consensus help to interpret the current evidence?

Antonis Valachis, Jürgen Geisler, Peeter Karihtala, Malgorzata Tuxen

se, no, fi, dk (code pays fourni par la source)

A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials

Shelley Potter, Kerry Avery, Rosina Ahmed, Jana de Boniface et autres

gb, in, se, ch, at, us, jp, il, nl, kr, Éthiopie, be, gr, it, au, Égypte, es, br, ru, ar, tr, pk, de, ca, th, ro, mt, hr, uy, cn, hk, cy, pt (code pays fourni par la source)

1690eP Stage III and IV malignant melanoma in Sweden: A nationwide study on health care resource utilization, productivity loss and associated cost, prescription drug use and survival prognosis

Antonis Valachis, Gustav Ullenhag, Hyunjin Park, P. Carlqvist et autres

se (code pays fourni par la source)

CN100 Clinical judgment, treatment decisions, and frailty management in older cancer patients: A qualitative study exploring the experiences of radiotherapy staff

Sofie Axelsson, P. Fessé, Per-Anders Fransson, Agneta Schröder et autres

se, no (code pays fourni par la source)

368P External validation of the PREDICT prognosis tool in young (≤40 years old) breast cancer patients in Sweden

Daniel R. Smith, Antonis Valachis, Christina Lundgren, I. Fredriksson

se (code pays fourni par la source)

Clinical Judgement, Treatment Decisions and Frailty Management in Older Cancer Patients: A Qualitative Study Exploring the Experiences of Radiation Therapy Staff

Sofia Axelsson, Per Fessé, Per-Anders Fransson, Agneta Schröder et autres

se, no (code pays fourni par la source)

Abstract P2-08-28: Implementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older Breast Cancer patients (IMPORTANT trial) – a pragmatic randomized-controlled trial

Emanuela Risi, Laura Biganzoli, Athina Christopoulou, Fjermeros et autres

229P Risk of recurrence and overall survival in Stage II and III ER+/HER2- early breast cancer: A population-based registry study in Sweden

Antonis Valachis, Johan Dalén, Karin Lindberg, B. Paulsson et autres

Metastatic triple-negative breast cancer – current treatment strategies in the Nordics: a modified Delphi study

Antonis Valachis, Peeter Karihtala, Jürgen Geisler, Malgorzata Tuxen

se, fi, no, dk (code pays fourni par la source)

Effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysis

Georgios Fountoukidis, Aglaia Schiza, Daniel R. Smith, Marie Bergman et autres

se (code pays fourni par la source)

Neoadjuvant compared to adjuvant chemotherapy combined with trastuzumab in patients with HER2-positive breast cancer: a register-based cohort study

Servah Hosseini-Mellner, Åsa Wickberg, Erik Olsson, Andreas Karakatsanis et autres

se (code pays fourni par la source)

Lessons learned from an unsuccessful decentralized clinical trial in Oncology

Antonis Valachis, Henrik Lindman

se, us (code pays fourni par la source)